Skip to content
Screener

Guardant Health GH Accrued Expenses

Accrued Expenses at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$39.8M-7.4%
NeoGenomics logo
NeoGenomicsNEO
$56.27M+15.9%
Illumina logo
IlluminaILMN
$848M+296%
Veracyte logo
VeracyteVCYT
$18.94M+1.3%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$906K+42.0%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$6.22M-3.0%

Other financials

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Operating income-$121.4M-9.3%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
CapEx$5.6M+25.1%
Free cash flow-$71.2M-6.0%

Valuation

See full
Market cap$21.9B+294%
Enterprise value$22.5B+265%
P/S20.3×+13.6×

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp
FCF margin-22%-6.7pp

Returns & leverage

See full
Return on equity-438.1%-1,655pp
Debt / equity
Current ratio4.7×+0.6×

Where this comes from

Reported directly by Guardant Health in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The source filing: Guardant Health’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 5:16 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001576280-26-000026
Line itemMarch 31, 2026December 31, 2025
Current liabilities:
Accounts payable$75,034$54,442
Accrued compensation91,326119,646
Accrued expenses78,01377,889
Deferred revenue47,77250,753
Total current liabilities292,145302,730
Convertible senior notes, net1,503,4711,504,000
Long-term operating lease liabilities173,055178,463

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Guardant Health's accrued expenses?
Guardant Health (GH) reported accrued expenses of $78.01M in Q1 2026.
How has Guardant Health's accrued expenses changed year-over-year?
Guardant Health's accrued expenses increased by 2.6% year-over-year, from $76M to $78.01M.
What is the long-term trend for Guardant Health's accrued expenses?
Over 5 years (2020 to 2025), Guardant Health's accrued expenses has grown at a 28.0% compound annual growth rate (CAGR), from $22.64M to $77.89M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Guardant Health's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude